[ad_1] Long-standing trade agreements have largely sheltered the pharmaceutical industry...
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
[ad_1] Sopa Images | Lightrocket | Getty ImagesBluebird Bio will...
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
[ad_1] Starting in his early teens, Deshawn "DJ" Chow wasn't...
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
[ad_1] A sign hangs in front of the world headquarters...